[1]
|
Thomas, F.T., Ricordi, C., Contreras, J.L., Hubbard, W.J., Jiang, X.L., Eckhoff, D.E., Cartner, S., Bilbao, G., Neville Jr., D.M. and Thomas, J.M. (1999) Reversal of Naturally Occurring Diabetes in Primates by Unmodified Islet Xenografts without Chronic Immunosuppression. Transplantation, 67, 846-854. https://doi.org/10.1097/00007890-199903270-00011
|
[2]
|
Dufrane, D., Goebbels, R.M. and Gianello, P. (2010) Alginate Macroencapsulation of Pig Islets Allows Correction of Streptozotocin-Induced Diabetes in Primates up to 6 Months without Immunosuppression. Transplantation, 90, 1054-1062. https://doi.org/10.1097/TP.0b013e3181f6e267
|
[3]
|
Srinivasan, K. and Ramarao, P. (2007) Animal Models in Type 2 Diabetes Research: an Overview. Indian Journal of Medical Research, 125, 451-472.
|
[4]
|
Drel, V.R., Pacher, P., Stavniichuk, R., Xu, W., Zhang, J., Kuchmerovska, T., Slusher, B. and Obrosova, I.G. (2011) Poly (ADP-Ribose) Polymerase Inhibition Counteracts Renal Hypertrophy and Multiple Manifestations of Peripheral Neuropathy in Diabetic Akita Mice. International Journal of Molecular Medicine, 28, 629-635.
|
[5]
|
Zhou, C., Pridgen, B., King, N., Xu, J. and Breslow, J.L. (2011) Hyperglycemic Ins2AkitaLdlr-/- Mice Show Severely Elevated Lipid Levels and Increased Atherosclerosis: A Model of Type 1 Diabetic Macrovascular Disease. Journal of Lipid Research, 52, 1483-1493. https://doi.org/10.1194/jlr.M014092
|
[6]
|
King, A.J. (2012) The Use of Animal Models in Diabetes Research. British Journal of Pharmacology, 166, 877-894. https://doi.org/10.1111/j.1476-5381.2012.01911.x
|
[7]
|
Wei, L., Lu, Y., He, S., Jin, X., Zeng, L., Zhang, S. and Deng, S. (2011) Induction of Diabetes with Signs of Autoimmunity in Primates by the Injection of Multiple-Low-Dose Streptozotocin. Biochemical and Biophysical Research Communications, 412, 373-378. https://doi.org/10.1016/j.bbrc.2011.07.105
|
[8]
|
Yoon, J.W., London, W.T., Curfman, B.L., Brown, R.L. and Notkins, A.L. (1986) Coxsackie Virus B4 Produces Transient Diabetes in Nonhuman Primates. Diabetes, 35, 712-716. https://doi.org/10.2337/diab.35.6.712
|
[9]
|
Brendle, T.A. (2010) Preventing Surgically Induced Diabetes after Total Pancreatectomy via Autologous Islet Cell Reimplantation. AORN Journal, 92, 169-184. https://doi.org/10.1016/j.aorn.2010.04.015
|
[10]
|
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L. and Ramarao, P. (2005) Combination of High-Fat Diet-Fed and Low-Dose Streptozotocin-Treated Rat: A Model for Type 2 Diabetes and Pharmacological Screening. Pharmacological Research, 52, 313-320. https://doi.org/10.1016/j.phrs.2005.05.004
|
[11]
|
Magalhaes, D.A., Kume, W.T., Correia, F.S., Queiroz, T.S., Allebrandt, E.W., Santos, M.P. and Franca, S.A. (2019) High-Fat Diet and Streptozotocin in the Induction of Type 2 Diabetes Mellitus: A New Proposal. Anais da Academia Brasileira de Ciências, 91, e20180314. https://doi.org/10.1590/0001-3765201920180314
|
[12]
|
Tesch, G.H. and Allen, T.J. (2007) Rodent Models of Streptozotocin‐Induced Diabetic Nephropathy (Methods in Renal Research). Nephrology, 12, 261-266. https://doi.org/10.1111/j.1440-1797.2007.00796.x
|
[13]
|
Arison, R.N., Ciaccio, E.I., Glitzer, M.S., Cassaro, J.A. and Pruss, M.P. (1967) Light and Electron Microscopy of Lesions in Rats Rendered Diabetic with Streptozotocin. Diabetes, 16, 51-56. https://doi.org/10.2337/diab.16.1.51
|
[14]
|
Lenzen, S. (2008) The Mechanisms of Alloxan- and Streptozotocin-Induced Diabetes. Diabetologia, 51, 216-226. https://doi.org/10.1007/s00125-007-0886-7
|
[15]
|
Thurston, D.E. and Pysz, I. (2021) Chemistry and Pharmacology of Anti-Cancer Drugs. CRC Press, Boca Raton. https://doi.org/10.1201/9781315374727
|
[16]
|
Szkudelski, T. (2001) The Mechanism of Alloxan and Streptozotocin Action in B Cells of the Rat Pancreas. Physiological Research, 50, 537-546.
|
[17]
|
Yang, H. and Wright Jr., J.R. (2002) Human β Cells Are Exceedingly Resistant to Streptozotocin in Vivo. Endocrinology, 143, 2491-2495. https://doi.org/10.1210/endo.143.7.8901
|
[18]
|
Elsner, M., Guldbakke, B., Tiedge, M., Munday, R. and Lenzen, S. (2000) Relative Importance of Transport and Alkylation for Pancreatic Beta-Cell Toxicity of Streptozotocin. Diabetologia, 43, 1528-1533. https://doi.org/10.1007/s001250051564
|
[19]
|
Busineni, J.G., Dwarakanath, V. and Chikka Swamy, B.K. (2015) Streptozotocin—A Diabetogenic Agent in Animal Models. International Journal of Pharmacy and Pharmaceutical Sciences, 3, 253-269.
|
[20]
|
Reed, M.J., Meszaros, K., Entes, L.J., Claypool, M.D., Pinkett, J.G., Gadbois, T.M. and Reaven, G.M. (2000) A New Rat Model of Type 2 Diabetes: The Fat-Fed, Streptozotocin-Treated Rat. Metabolism-Clinical and Experimental, 49, 1390-1394. https://doi.org/10.1053/meta.2000.17721
|
[21]
|
Spinas, G.A. (1999) The Dual Role of Nitric Oxide in Islet Β-Cells. Physiology, 14, 49-54. https://doi.org/10.1152/physiologyonline.1999.14.2.49
|
[22]
|
Qian, C., Zhu, C., Yu, W., Jiang, X. and Zhang, F. (2015) High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells. PLOS ONE, 10, e0136390. https://doi.org/10.1371/journal.pone.0136390
|
[23]
|
Deeds, M.C., Anderson, J.M., Armstrong, A.S., Gastineau, D.A., Hiddinga, H.J., Jahangir, A. and Kudva, Y.C. (2011) Single Dose Streptozotocin-Induced Diabetes: Considerations for Study Design in Islet Transplantation Models. Laboratory Animals, 45, 131-140. https://doi.org/10.1258/la.2010.010090
|
[24]
|
Tanaka, S., Hayashi, T., Toyoda, T., Hamada, T., Shimizu, Y., Hirata, M. and Nakao, K. (2007) High-Fat Diet Impairs the Effects of a Single Bout of Endurance Exercise on Glucose Transport and Insulin Sensitivity in Rat Skeletal Muscle. Metabolism, 56, 1719-1728. https://doi.org/10.1016/j.metabol.2007.07.017
|
[25]
|
Flanagan, A.M., Brown, J.L., Santiago, C.A., Aad, P.Y., Spicer, L.J. and Spicer, M.T. (2008) High-Fat Diets Promote Insulin Resistance through Cytokine Gene Expression in Growing Female Rats. The Journal of Nutritional Biochemistry, 19, 505-513. https://doi.org/10.1016/j.jnutbio.2007.06.005
|
[26]
|
Liu, Z., Wang, N., Ma, Y. and Wen, D. (2019) Hydroxytyrosol Improves Obesity and Insulin Resistance by Modulating Gut Microbiota in High-Fat Diet-Induced Obese Mice. Frontiers in Microbiology, 10, Article 390. https://doi.org/10.3389/fmicb.2019.00390
|
[27]
|
Zhou, J., Zhou, S., Tang, J., Zhang, K., Guang, L., Huang, Y. and Li, D. (2009) Protective Effect of Berberine on Beta Cells in Streptozotocin- and High-Carbohydrate/High-Fat Diet-Induced Diabetic Rats. European Journal of Pharmacology, 606, 262-268. https://doi.org/10.1016/j.ejphar.2008.12.056
|
[28]
|
Kopelman, P. (2007) Health Risks Associated with Overweight and Obesity. Obesity Reviews, 8, 13-17. https://doi.org/10.1111/j.1467-789X.2007.00311.x
|
[29]
|
Fawcett, K.A. and Barroso, I. (2010) The Genetics of Obesity: FTO Leads the Way. Trends in Genetics, 26, 266-274. https://doi.org/10.1016/j.tig.2010.02.006
|
[30]
|
Dina, C., Meyre, D., Gallina, S., Durand, E., Korner, A., Jacobson, P. and Froguel, P. (2007) Variation in FTO Contributes to Childhood Obesity and Severe Adult Obesity. Nature Genetics, 39, 724-726. https://doi.org/10.1038/ng2048
|
[31]
|
Scuteri, A., Sanna, S., Chen, W.M., Uda, M., Albai, G., Strait, J. and Abecasis, G.R. (2007) Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits. PLOS Genetics, 3, e115. https://doi.org/10.1371/journal.pgen.0030115
|
[32]
|
Claussnitzer, M., Dankel, S.N., Kim, K.H., Quon, G., Meuleman, W., Haugen, C. and Kellis, M. (2015) FTO Obesity Variant Circuitry and Adipocyte Browning in Humans. New England Journal of Medicine, 373, 895-907. https://doi.org/10.1056/NEJMoa1502214
|
[33]
|
McMurray, F., Church, C.D., Larder, R., Nicholson, G., Wells, S., Teboul, L. and Cox, R.D. (2013) Adult Onset Global Loss of the Fto Gene Alters Body Composition and Metabolism in the Mouse. PLOS Genetics, 9, e1003166. https://doi.org/10.1371/journal.pgen.1003166
|
[34]
|
Popa, S. and Mota, M. (2013) Beta-Cell Function and Failure in Type 2 Diabetes. In: Masuo, K., Ed., Type 2 Diabetes, InTech, Croatia, 29-50. https://doi.org/10.5772/56467
|
[35]
|
Poitout, V. and Robertson, R.P. (2008) Glucolipotoxicity: Fuel EXCESS and β-Cell Dysfunction. Endocrine Reviews, 29, 351-366. https://doi.org/10.1210/er.2007-0023
|
[36]
|
Acheson, K.J., Schutz, Y., Bessard, T., Anantharaman, K., Flatt, J.P. and Jequier, E. (1988) Glycogen Storage Capacity and de Novo Lipogenesis during Massive Carbohydrate Overfeeding in Man. The American Journal of Clinical Nutrition, 48, 240-247. https://doi.org/10.1093/ajcn/48.2.240
|
[37]
|
Kahn, S.E. (2003) The Relative Contributions of Insulin Resistance and Beta-Cell Dysfunction to the Pathophysiology of Type 2 Diabetes. Diabetologia, 46, 3-19. https://doi.org/10.1007/s00125-002-1009-0
|
[38]
|
Marchetti, P., Dotta, F., Lauro, D. and Purrello, F. (2008) An Overview of Pancreatic Beta-Cell Defects in Human Type 2 Diabetes: Implications for Treatment. Regulatory Peptides, 146, 4-11. https://doi.org/10.1016/j.regpep.2007.08.017
|
[39]
|
Blüher, M. (2010) The Distinction of Metabolically ‘Healthy’ from ‘Unhealthy’ Obese Individuals. Current Opinion in Lipidology, 21, 38-43. https://doi.org/10.1097/MOL.0b013e3283346ccc
|
[40]
|
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K. and Walter, P. (2002) Blood Vessels and Endothelial Cells. In: Molecular Biology of the Cell, 4th Edition, Garland Science, New York.
|
[41]
|
Abdesselem, H.B., Madani, A. and Mazloum, N. (2012) Investigating Poly (ADP-Ribose) Polymerase-1 (PARP-1) Activation in Obesity Associated DNA Damage and Pro-Inflammatory Senescence. Qatar Foundation Annual Research Forum, 2012, BMP77. https://doi.org/10.5339/qfarf.2012.BMP77
|
[42]
|
Skovso, S. (2014) Modeling Type 2 Diabetes in Rats Using High Fat Diet and Streptozotocin. Journal of Diabetes Investigation, 5, 349-358. https://doi.org/10.1111/jdi.12235
|
[43]
|
Benito-Vicente, A., Jebari-Benslaiman, S., Galicia-Garcia, U., Larrea-Sebal, A., Uribe, K.B. and Martin, C. (2021) Molecular Mechanisms of Lipotoxicity-Induced Pancreatic β-Cell Dysfunction. International Review of Cell and Molecular Biology, 359, 357-402. https://doi.org/10.1016/bs.ircmb.2021.02.013
|
[44]
|
Levy, J., Atkinson, A.B., Bell, P.M., McCance, D.R. and Hadden, D.R. (1998) Beta-Cell Deterioration Determines the Onset and Rate of Progression of Secondary Dietary Failure in Type 2 Diabetes Mellitus: The 10-Year Follow-Up of the Belfast Diet Study. Diabetic Medicine, 15, 290-296. https://doi.org/10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M
|
[45]
|
Chen, C., Hosokawa, H., Bumbalo, L.M. and Leahy, J.L. (1994) Mechanism of Compensatory Hyperinsulinemia in Normoglycemic Insulin-Resistant Spontaneously Hypertensive Rats. Augmented Enzymatic Activity of Glucokinase in Beta-Cells. The Journal of Clinical Investigation, 94, 399-404. https://doi.org/10.1172/JCI117335
|
[46]
|
Liu, Y.Q., Jetton, T.L. and Leahy, J.L. (2002) β-Cell Adaptation to Insulin Resistance: Increased Pyruvate Carboxylase and Malate-Pyruvate Shuttle Activity in Islets of Nondiabetic Zucker Fatty Rats. Journal of Biological Chemistry, 277, 39163-39168. https://doi.org/10.1074/jbc.M207157200
|
[47]
|
Kliewer, S.A., Sundseth, S.S., Jones, S.A., Brown, P.J., Wisely, G.B., Koble, C.S. and Lehmann, J.M. (1997) Fatty Acids and Eicosanoids Regulate Gene Expression through Direct Interactions with Peroxisome Proliferator-Activated Receptors α and γ. Proceedings of the National Academy of Sciences of the United States of America, 94, 4318-4323. https://doi.org/10.1073/pnas.94.9.4318
|
[48]
|
Plotz, T., Krümmel, B., Laporte, A., Pingitore, A., Persaud, S.J., Jorns, A. and Lenzen, S. (2017) The Monounsaturated Fatty Acid Oleate Is the Major Physiological Toxic Free Fatty Acid for Human Beta Cells. Nutrition and Diabetes, 7, Article No. 305. https://doi.org/10.1038/s41387-017-0005-x
|
[49]
|
Guberski, D.L., Butler, L., Manzi, S.M., Stubbs, M. and Like, A.A. (1993) The BBZ/Wor Rat: Clinical Characteristics of the Diabetic Syndrome. Diabetologia, 36, 912-919. https://doi.org/10.1007/BF02374472
|
[50]
|
Fortuno, A., Rodriguez, A., Gomez-Ambrosi, J., Frühbeck, G. and Diez-Martinez, J. (2003) Adipose Tissue as an Endocrine Organ: Role of Leptin and Adiponectin in the Pathogenesis of Cardiovascular Diseases. Journal of Physiology and Biochemistry, 59, 51-60. https://doi.org/10.1007/BF03179868
|
[51]
|
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L. and Friedman, J.M. (1994) Positional Cloning of the Mouse Obese Gene and Its Human Homologue. Nature, 372, 425-432. https://doi.org/10.1038/372425a0
|
[52]
|
Haynes, W.G., Morgan, D.A., Walsh, S., Mark, A.L. and Sivitz, W.I. (1997) Receptor-Mediated Regional Sympathetic Nerve Activation by Leptin. The Journal of Clinical Investigation, 100, 270-278. https://doi.org/10.1172/JCI119532
|
[53]
|
Zhou, Y.T., Shimabukuro, M., Koyama, K., Lee, Y., Wang, M.Y., Trieu, F. and Unger, R.H. (1997) Induction by Leptin of Uncoupling Protein-2 and Enzymes of Fatty Acid Oxidation. Proceedings of the National Academy of Sciences of the United States of America, 94, 6386-6390. https://doi.org/10.1073/pnas.94.12.6386
|
[54]
|
Miller, M., Seidler, A., Moalemi, A. and Pearson, T.A. (1998) Normal Triglyceride Levels and Coronary Artery Disease Events: The Baltimore Coronary Observational Long-Term Study. Journal of the American College of Cardiology, 31, 1252-1257. https://doi.org/10.1016/S0735-1097(98)00083-7
|
[55]
|
Unger, R.H. and Zhou, Y.T. (2001) Lipotoxicity of Beta-Cells in Obesity and in Other Causes of Fatty Acid Spillover. Diabetes, 50, S118. https://doi.org/10.2337/diabetes.50.2007.S118
|
[56]
|
Shimabukuro, M., Zhou, Y.T., Levi, M. and Unger, R.H. (1998) Fatty Acid-Induced β cell Apoptosis: A Link between Obesity and Diabetes. Proceedings of the National Academy of Sciences of the United States of America, 95, 2498-2502. https://doi.org/10.1073/pnas.95.5.2498
|
[57]
|
Sahin, K., Onderci, M., Tuzcu, M., Ustundag, B., Cikim, G., Ozercan, I.H. and Komorowski, J.R. (2007) Effect of Chromium on Carbohydrate and Lipid Metabolism in a Rat Model of Type 2 Diabetes Mellitus: The Fat-Fed, Streptozotocin-Treated Rat. Metabolism, 56, 1233-1240. https://doi.org/10.1016/j.metabol.2007.04.021
|
[58]
|
Lee, Y., Hiros, H., Zhou, Y. T., Esser, V., McGarry, J.D. and Unger, R.H. (1997) Increased Lipogenic Capacity of the Islets of Obese Rats: A Role in the Pathogenesis of NIDDM. Diabetes, 46, 408-413. https://doi.org/10.2337/diab.46.3.408
|
[59]
|
Pautz, A., Franzen, R., Dorsch, S., Boddinghaus, B., Briner, V.A., Pfeilschifter, J. and Huwiler, A. (2002) Cross-Talk between Nitric Oxide and Superoxide Determines Ceramide Formation and Apoptosis in Glomerular Cells. Kidney International, 61, 790-796. https://doi.org/10.1046/j.1523-1755.2002.00222.x
|
[60]
|
Zhang, D.X., Zou, A.P. and Li, P.L. (2003) Ceramide-Induced Activation of NADPH Oxidase and Endothelial Dysfunction in Small Coronary Arteries. American Journal of Physiology-Heart and Circulatory Physiology, 284, H605-H612. https://doi.org/10.1152/ajpheart.00697.2002
|
[61]
|
Burcelin, R., Kande, J., Ricquier, D. and Girard, J. (1993) Changes in Uncoupling Protein and GLUT4 Glucose Transporter Expressions in Interscapular Brown Adipose Tissue of Diabetic Rats: Relative Roles of Hyperglycaemia and Hypoinsulinaemia. Biochemical Journal, 291, 109-113. https://doi.org/10.1042/bj2910109
|
[62]
|
Dolan, M.E. (1997) Inhibition of DNA Repairs as a Means of Increasing the Antitumor Activity of DNA Reactive Agents. Advanced Drug Delivery Reviews, 26, 105-118. https://doi.org/10.1016/S0169-409X(97)00028-8
|
[63]
|
Weiss, R.B. (1982) Streptozocin: A Review of Its Pharmacology, Efficacy, and Toxicity. Cancer Treatment Reports, 66, 427-438.
|
[64]
|
Schott, M., Scherbaum, W.A. and Feldkamp, J. (2000) Drug Therapy of Endocrine Neoplasms. Part II: Malignant Gastrinomas, Insulinomas, Glucagonomas, Carcinoids and Other Tumors. Medizinische Klinik (Munich, Germany: 1983), 95, 81-84. https://doi.org/10.1007/BF03044988
|
[65]
|
Rerup, C. and Tarding, F. (1969) Streptozotocin- and Alloxan-Diabetes in Mice. European Journal of Pharmacology, 7, 89-96. https://doi.org/10.1016/0014-2999(69)90169-1
|
[66]
|
Vivek, K.S. (2010) Streptozotocin: An Experimental Tool in Diabetes and Alzheimer’s Disease (A-Review). International Journal of Pharmaceutical Research and Development, 2, 1-7.
|
[67]
|
Eleazu, C.O., Eleazu, K.C., Chukwuma, S. and Essien, U.N. (2013) Review of the Mechanism of Cell Death Resulting from Streptozotocin Challenge in Experimental Animals, Its Practical Use and Potential Risk to Humans. Journal of Diabetes and Metabolic Disorders, 12, Article No. 60. https://doi.org/10.1186/2251-6581-12-60
|
[68]
|
Sanguinetti, R.E., Ogawa, K., Kurohmaru, M. and Hayashi, Y. (1995) Ultrastructural Changes in Mouse Leydig Cells after Streptozotocin Administration. Experimental Animals, 44, 71-73. https://doi.org/10.1538/expanim.44.71
|
[69]
|
Ahlgren, S.C. and Levine, J.D. (1993) Mechanical Hyperalgesia in Streptozotocin-Diabetic Rats. Neuroscience, 52, 1049-1055. https://doi.org/10.1016/0306-4522(93)90551-P
|
[70]
|
Fiordaliso, F., Li, B., Latini, R., Sonnenblick, E.H., Anversa, P., Leri, A. and Kajstura, J. (2000) Myocyte Death in Streptozotocin-Induced Diabetes in Rats Is Angiotensin II-Dependent. Laboratory Investigation, 80, 513-527. https://doi.org/10.1038/labinvest.3780057
|
[71]
|
Katsumata, K. and Katsumata, Y. (1992) Protective Effect of Diltiazem Hydrochloride on the Occurrence of Alloxan- or Streptozotocin-Induced Diabetes in Rats. Hormone and Metabolic Research, 24, 508-510. https://doi.org/10.1055/s-2007-1003376
|
[72]
|
Ito, M., Kondo, Y., Nakatani, A., Hayashi, K. and Naruse, A. (2001) Characterization of Low Dose Streptozotocin-Induced Progressive Diabetes in Mice. Environmental Toxicology and Pharmacology, 9, 71-78. https://doi.org/10.1016/S1382-6689(00)00064-8
|
[73]
|
Nakamura, M., Nagafuchi, S., Yamaguchi, K. and Takaki, R. (1984) The Role of Thymic Immunity And Insulitis in the Development of Streptozocin-Induced Diabetes in Mice. Diabetes, 33, 894-900. https://doi.org/10.2337/diab.33.9.894
|
[74]
|
Leturque, A., Brot-Laroche, E. and Le Gall, M. (2009) GLUT2 Mutations, Translocation, and Receptor Function in Diet Sugar Managing. American Journal of Physiology. Endocrinology and Metabolism, 296, E985-E992. https://doi.org/10.1152/ajpendo.00004.2009
|
[75]
|
Narasimhan, A., Chinnaiyan, M. and Karundevi, B. (2015) Ferulic Acid Regulates Hepatic GLUT2 Gene Expression in High Fat and Fructose-Induced Type-2 Diabetic Adult Male Rat. European Journal of Pharmacology, 761, 391-397. https://doi.org/10.1016/j.ejphar.2015.04.043
|
[76]
|
Kahraman, S., Aydin, C., Elpek, G. O., Dirice, E. and Sanlioglu, A. D. (2015) Diabetes-Resistant NOR Mice Are More Severely Affected by Streptozotocin Compared to the Diabetes-Prone NOD Mice: Correlations with Liver and Kidney GLUT2 Expressions. Journal of Diabetes Research, 2015, Article ID: 450128. https://doi.org/10.1155/2015/450128
|
[77]
|
Ventura-Sobrevilla, J., Boone-Villa, V.D., Aguilar, C.N., Román-Ramos, R., Vega-Avila, E., Campos-Sepúlveda, E. and Alarcón-Aguilar, F. (2011) Effect of Varying Dose and Administration of Streptozotocin on Blood Sugar in Male CD1 Mice. Proceedings of the Western Pharmacology Society, 54, 5-9.
|
[78]
|
Kramer, J., Moeller, E.L., Hachey, A., Mansfield, K.G. and Wachtman, L.M. (2009) Differential Expression of GLUT2 in Pancreatic Islets and Kidneys of New and Old World Nonhuman Primates. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 296, R786-R793. https://doi.org/10.1152/ajpregu.90694.2008
|
[79]
|
Elsner, M., Tiedge, M. and Lenzen, S. (2003) Mechanism Underlying Resistance of Human Pancreatic Beta Cells against Toxicity of Streptozotocin and Alloxan. Diabetologia, 46, 1713-1714. https://doi.org/10.1007/s00125-003-1241-2
|
[80]
|
Eizirik, D.L., Pipeleers, D.G., Ling, Z., Welsh, N., Hellerstrom, C. and Andersson, A. (1994) Major Species Differences Between Humans and Rodents in the Susceptibility to Pancreatic Beta-Cell Injury. Proceedings of the National Academy of Sciences of the United States of America, 91, 9253-9256. https://doi.org/10.1073/pnas.91.20.9253
|
[81]
|
Tyrberg, B., Andersson, A. and Borg, L.H. (2001) Species Differences in Susceptibility of Transplanted and Cultured Pancreatic Islets to the Β-Cell Toxin Alloxan. General and Comparative Endocrinology, 122, 238-251. https://doi.org/10.1006/gcen.2001.7638
|
[82]
|
Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P. and Uusitupa, M. (2001) Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance. New England Journal of Medicine, 344, 1343-1350. https://doi.org/10.1056/NEJM200105033441801
|
[83]
|
Ledoux, S.P. and Wilson, G.L. (1984) Effects of Streptozotocin on a Conal Isolate of Rat Insulinoma Cells. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 804, 387-392. https://doi.org/10.1016/0167-4889(84)90064-8
|
[84]
|
Flatt, P.R., Swanston-Flatt, S.K., Tan, K.S. and Marks, V. (1987) Effects of Cytotoxic Drugs and Inhibitors of Insulin Secretion on a Serially Transplantable Rat Insulinoma and Cultured Rat Insulinoma Cells. General Pharmacology, 18, 293-297. https://doi.org/10.1016/0306-3623(87)90014-0
|
[85]
|
Schnedl, W.J., Ferber, S., Johnson, J.H. and Newgard, C.B. (1994) STZ Transport and Cytotoxicity: Specific Enhancement in GLUT2-Expressing Cells. Diabetes, 43, 1326-1333. https://doi.org/10.2337/diab.43.11.1326
|
[86]
|
Kim, Y.B., Iwashita, S., Tamura, T., Tokuyama, K. and Suzuki, M. (1995) Effect of High-Fat Diet on the Gene Expression of Pancreatic GLUT2 and Glucokinase in Rats. Biochemical and Biophysical Research Communications, 208, 1092-1098. https://doi.org/10.1006/bbrc.1995.1446
|
[87]
|
Ohneda, M., Johnson, J.H., Inman, L.R., Chen, L., Suzuki, K.I., Goto, Y., et al. (1993) GLUT2 Expression and Function in β-Cells of GK Rats with NIDDM: Dissociation between Reductions in Gucose Tansport and Glucose-Stimulated Insulin Secretion. Diabetes, 42, 1065-1072. https://doi.org/10.2337/diab.42.7.1065
|
[88]
|
Johnson, J.H., Ogawa, A., Chen, L., Orci, L., Newgard, C.B., Alam, T. and Unger, R.H. (1990) Underexpression of β Cell High K m Glucose Transporters in Noninsulin-Dependent Diabetes. Science, 250, 546-549. https://doi.org/10.1126/science.2237405
|
[89]
|
Orci, L., Unger, R.H., Ravazzola, M., Ogawa, A., Komiya, I., Baetens, D. and Thorens, B. (1990) Reduced Beta-Cell Glucose Transporter in New Onset Diabetic BB Rats. The Journal of Clinical Investigation, 86, 1615-1622. https://doi.org/10.1172/JCI114883
|
[90]
|
Tal, M.G. (2009) Type 2 Diabetes: Microvascular Ischemia of Pancreatic Iislets? Medical Hypotheses, 73, 357-358. https://doi.org/10.1016/j.mehy.2009.03.034
|
[91]
|
Saini, K.S., Thompson, C., Winterford, C.M., Walker, N.I. and Cameron, D.P. (1996) Streptozotocin at Low Doses Induces Apoptosis and at High Doses Causes Necrosis in a Murine Pancreatic β Cell Line, INS-1. IUBMB Life, 39, 1229-1236. https://doi.org/10.1080/15216549600201422
|
[92]
|
Murata, M., Takahashi, A., Saito, I. and Kawanishi, S. (1999) Site-Specific DNA Methylation and Apoptosis: Induction by Diabetogenic Streptozotocin. Biochemical Pharmacology, 57, 881-887. https://doi.org/10.1016/S0006-2952(98)00370-0
|
[93]
|
Wilson, G.L. and Leiter, E.H. (1990) Streptozotocin Interactions with Pancreatic β Cells and the Induction of Insulin-Dependent Diabetes. In: Dyrberg, T., Ed., The Role of Viruses and the Immune System in Diabetes Mellitus. Current Topics in Microbiology and Immunology, Springer, Berlin, 27-54. https://doi.org/10.1007/978-3-642-75239-1_3
|
[94]
|
Bennett, R.A. and Pegg, A.E. (1981) Alkylation of DNA in Rat Tissues Following Administration of Streptozotocin. Cancer Research, 41, 2786-2790.
|
[95]
|
Pieper, A.A., Brat, D.J., Krug, D.K., Watkins, C.C., Gupta, A., Blackshaw, S. and Snyder, S.H. (1999) Poly(ADP-Ribose) Polymerase-Deficient Mice Are Protected from Streptozotocin-Induced Diabetes. Proceedings of the National Academy of Sciences of the United States of America, 96, 3059-3064. https://doi.org/10.1073/pnas.96.6.3059
|
[96]
|
Kroncke, K.D., Fehsel, K., Sommer, A., Rodriguez, M.L. and Kolb-Bachofen, V. (1995) Nitric Oxide Generation during Cellular Metabolization of the Diabetogenic N-Methyl-N-nitroso-urea Streptozotozin Contributes to Islet Cell DNA Damage. Biological Chemistry Hoppe-Seyler, 376, 179-185. https://doi.org/10.1515/bchm3.1995.376.3.179
|
[97]
|
Malinski, T. (2000) The Vital Role of Nitric Oxide. Oakland Journal, No. 1, 47-57. https://our.oakland.edu/bitstream/handle/10323/7516/01_Malinski.pdf?sequence=1
|
[98]
|
Wada, R. and Yagihashi, S. (2004) Nitric Oxide Generation and Poly (ADP Ribose) Polymerase Activation Precede Beta-Cell Death in Rats with a Single High-Dose Injection of Streptozotocin. Virchows Archiv, 444, 375-382. https://doi.org/10.1007/s00428-003-0967-z
|
[99]
|
Miura, D., Wada, N. and Brunaud, L. (2005) Comparative Genomic Hybridization in Thyroid Neoplasms. In: Clark, O.H., Duh, Q.-Y. and Kebebew, E., Eds., Textbook of Endocrine Surgery, WB Saunders, Philadelphia, PA, 344-354. https://doi.org/10.1016/B978-0-7216-0139-7.50040-5
|
[100]
|
Mori, M. (2007) Regulation of Nitric oxide Synthesis and Apoptosis by Arginase and Arginine Recycling. The Journal of Nutrition, 137, 1616S-1620S. https://doi.org/10.1093/jn/137.6.1616S
|
[101]
|
Turk, J., Corbett, J., Ramanadham, S., Bohrer, A. and McDaniel, M.L. (1993) Biochemical Evidence for Nitric Oxide Formation from Streptozotocin in Isolated Pancreatic Islets. Biochemical and Biophysical Research Communications, 197, 1458-1464. https://doi.org/10.1006/bbrc.1993.2641
|
[102]
|
Thorens, B., Weir, G.C., Leahy, J.L., Lodish, H.F. and Bonner-Weir, S. (1990) Reduced Expression of the Liver/Beta-cell Glucose Transporter Isoform in Glucose-Insensitive Pancreatic Beta Cells of Diabetic Rats. Proceedings of the National Academy of Sciences of the United States of America, 87, 6492-6496. https://doi.org/10.1073/pnas.87.17.6492
|
[103]
|
Tousoulis, D., Kampoli, A.-M., Tentolouris, C., Papageorgiou, N. and Stefanadis, C. (2012) The Role of Nitric Oxide on Endothelial Function. Current Vascular Pharmacology, 10, 4-18. https://doi.org/10.2174/157016112798829760
|
[104]
|
Castro, L., Rodriguez, M. and Radi, R. (1994) Aconitase Is Readily Inactivated by Peroxynitrite, but Not by Its Precursor, Nitric Oxide. Journal of Biological Chemistry, 269, 29409-29415. https://doi.org/10.1016/S0021-9258(18)43894-X
|
[105]
|
Nukatsuka, M., Yoshimura, Y., Nishida, M. and Kawada, J. (1990) Allopurinol Protects Pancreatic β Cells from the Cytotoxic Effect of Streptozotocin: In Vitro Study. Journal of Pharmacobio-Dynamics, 13, 259-262. https://doi.org/10.1248/bpb1978.13.259
|
[106]
|
Takasu, N., Komiya, I., Asawa, T., Nagasawa, Y. and Yamada, T. (1991) Streptozocin- and Alloxan-Induced H2O2 Generation and DNA Fragmentation in Pancreatic Islets: H2O2 as Mediator for DNA Fragmentation. Diabetes, 40, 1141-1145. https://doi.org/10.2337/diab.40.9.1141
|
[107]
|
Raza, H., Prabu, S.K., John, A. and Avadhani, N.G. (2011) Impaired Mitochondrial Respiratory Functions and Oxidative Stress in Streptozotocin-Induced Diabetic Rats. International Journal of Molecular Sciences, 12, 3133-3147. https://doi.org/10.3390/ijms12053133
|